Last reviewed · How we verify
NCT07365943
The Effect of Forgiveness-based Motivational Interviewing
NA trial testing forgiveness-based motivational interviewing in Psychiatric Nursing in 30 participants. Completed in 30 September 2024.
27 September 2024
Quick facts
| Lead sponsor | Ömer USLU |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 30 |
| Start date | 1 June 2024 |
| Primary completion | 27 September 2024 |
| Estimated completion | 30 September 2024 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- forgiveness-based motivational interviewing
- Control
Conditions studied
- Psychiatric Nursing — all drugs for Psychiatric Nursing →
- Psychoeducation — all drugs for Psychoeducation →
- COPD (Chronic Obstructive Pulmonary Disease) — all drugs for COPD (Chronic Obstructive Pulmonary Disease) →
- Forgiveness — all drugs for Forgiveness →
Sponsor
Ömer USLU
Who can join
Adults 18 to 75, female only, with Psychiatric Nursing or Psychoeducation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aimed to examine the effect of forgiveness-based motivational interviewing on death anxiety, life satisfaction, and forgiveness disposition in patients with COPD. A randomized controlled experimental design with pretest, posttest, and one-month follow-up measurements was employed. The study sample consisted of 30 patients (experimental group: 15; control group: 15). The experimental group received forgiveness-based motivational interviewing, whereas no intervention was provided to the control group. Data were collected using a personal information form, the Death Anxiety Scale, the Life Satisfaction Scale, and the Forgiveness Scale. The findings revealed that, in the posttest and follow-up measurements, the experimental group had significantly lower mean scores on the Death Anxiety Scale compared to the control group (p\<0.05). Furthermore, the experimental group demonstrated significantly higher mean scores on the Life Satisfaction Scale and the Forgiveness Scale in the posttest and follow-up measurements than the control group (p\<0.05). This study concluded that forgiveness-based motivational interviewing effectively reduces death anxiety while enhancing life satisfaction and forgiveness disposition in patients with COPD. Therefore, implementing motivational interviewing for patients is recommended.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07365943
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Ömer USLU trials
Trials by the same sponsor.
- NCT07305571 — The Effect of Psychodrama-Based Group Work · NA · completed
- NCT07297056 — Mindfulness Psychoeducation for Bipolar Disorder · NA · completed
- NCT07310615 — Mindfulness Psychoeducation for Schizophrenia · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07365943 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ömer USLU
- Last refreshed: 26 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07365943.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing